When: Q3 2026 print late October with gross margin ≥60% AND disciplined FY27 input-cost guidance

Then: Upgrade to Overweight at 80-85% of benchmark

When: Q3 print with margin compression AND elevated input-cost disclosure

Then: Trim further toward Sell/40% sizing

When: Confirmed close below $87.05 with volume >5M

Then: Exit residual entirely, wait for $84.50 spring-low retest before re-engaging

Trim 60-70% at current ~$87.50, hold 30-40% core position with weekly close stop below $86.50; do not sell into resistance

• Beta of 0.32 is a portfolio hedge, not a directional liability; provides value in risk-off rotations when defensives earn their keep
• FCF of $3.46 billion with 5% FCF yield supports the multiple; net debt declined from $7.54 billion to $6.49 billion over the past year
• Current ratio improving from 0.93 to 1.026; dividend sustainable with FCF coverage more than 1 times dividends paid
• Revenue has grown sequentially for six consecutive quarters
• 200 SMA at $87.05 has not been broken; price hovering at lower Bollinger Band with orderly volume and low ATR of 1.69
• $1 billion divestiture of Softsoap, Irish Spring, and Speed Stick with Goldman Sachs advising could be accretive to margins and EPS
• 2.41% dividend yield is below inflation but compounds; provides defensive ballast in portfolio
• Selling on rallies to $89-$90 (10 EMA resistance that has failed 4 times in 6 weeks) is low probability execution

→ vs aggressive: 30-50% trim is 'half-measure thinking dressed up in a suit' and 'optionality preservation for ego at expense of firm's capital'

→ vs aggressive: Beta of 0.32 argument is 'one of the most confused arguments'; low beta is why the stock gets held as defensive ballast

→ vs aggressive: Attack on dividend yield is 'particularly weak'; 2.41% compounds and survived 2008 and COVID

→ vs aggressive: Technical interpretation omits critical context: 200 SMA intact, orderly volume, controlled bleed not collapse

→ vs aggressive: Selling ahead of $1B divestiture catalyst is selling ahead of news that could be materially accretive

→ vs aggressive: Stop loss placement at $87.05 is too tight; major technical levels are tested multiple times before breaking; needs weekly close basis with buffer

Trim 40-50% of position total in two tranches: 25% at current market near $87.50, then 15-25% more on rally toward $89-90 if it materializes; hold remaining 50-60% with closing stop below $87.00

• Structural yield gap of 259 basis points confirmed by technicals and macro backdrop
• CL at 21x forward vs 5% 10-year yields thin equity risk premium for low single-digit organic grower
• 5% FCF yield on $69B market cap leaves razor-thin risk premium vs 5% risk-free rate
• $3.46B in trailing FCF provides substantial cash return floor supporting dividend and buyback
• 2.41% dividend yield compounded quarterly provides participation while waiting for multiple compression
• $1B divestiture of mature mass market brands is portfolio optimization, not defensive selling—divesting into Walmart/Target price war is potentially accretive
• Beta of 0.32 provides portfolio hedge value in defensive regime
• September 21 S&P 100 deletion creates known mechanical passive selling pressure
• Lower Bollinger Band ride could resolve with breakdown if 200 SMA at $87.05 gives way on elevated volume
• Three catalysts in next six months: Q3 earnings (late October), $1B divestiture announcement, Q1 2027 US stabilization thesis
• Aggressive trim into known flow event is overconfidence in bear case— Polymarket probabilities are not destiny

→ vs aggressive: Calling 30-50% trim 'disciplined' is hedging, not bold—the bold move would be 70%+; also dismissing $3.46B FCF as irrelevant footnote when 5% FCF yield is a substantial return floor

→ vs aggressive: Misreading $1B divestiture as 'defensive language' when divesting mature brands into Walmart/Target price war and redeploying toward higher-margin oral care is portfolio optimization

→ vs aggressive: Claiming no catalyst for two quarters ignores divestiture news, Q3 earnings, and potential macro regime shift—three meaningful catalysts in next six months

→ vs conservative: Selling 60-70% at market near $87.50 is selling right at lower Bollinger Band and 200 SMA support level—if support holds, money left on table at worst price action

→ vs conservative: Labeling 60-70% trim as 'more conservative' ignores sequencing problem—selling into known September 21 rebalance is aggressive execution choice given mechanical selling pressure hitting tape

→ vs conservative: Weekly close stop at $86.50 is too slow for a stock that can move meaningfully between weekly prints given September catalyst calendar